Please login to the form below

Not currently logged in
Email:
Password:

Peter Kelly named managing director of Accord Healthcare UK

He was previously commercial director at Actavis UK

Peter Kelly Accord Healthcare ActavisAccord Healthcare has appointed Peter Kelly as its UK managing director, a move that sees him transition from Actavis, whose UK and Ireland operations Accord acquired last year.

Kelly spent 12 years at Actavis, most recently as commercial director. The Actavis Generics business was acquired from Allergan in 2016 by Teva, which then sold a chunk of it to Accord Healthcare, a subsidiary of Indian generics firm Intas Pharmaceuticals.

Kelly said: “Accord Healthcare is one of the fastest growing generic pharmaceutical companies in the UK, with us supplying one in six of the UK’s generic medicines. We remain committed to R&D and bringing cost competitive new products to market at the earliest opportunity.

“This is an exciting opportunity to lead our teams of brilliant people who continue to focus on excellent service, allowing us to work in partnership with customers as their Partner of Choice.”

Meanwhile, former Actavis UK managing director Jonathan Wilson has been appointed vice president, West Europe at Accord Healthcare.

He spent three years heading up Actavis’ UK operations and before that help senior commercial roles at Sandoz and Novartis.

11th July 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics